Financhill
Back

Inhibrx Biosciences, Inc. Vs. Corcept Therapeutics, Inc. Industry Stock Comparison

Sell
44

INBX
Inhibrx Biosciences, Inc.

Last Price:
$78.82
Seasonality Move:
-1.59%
Sell
30

CORT
Corcept Therapeutics, Inc.

Last Price:
$34.79
Seasonality Move:
13.21%
Sell
44
Inhibrx Biosciences, Inc. (INBX) is a Sell

Is Inhibrx Biosciences, Inc. a Buy, Sell or Hold?

  • The current Inhibrx Biosciences, Inc. [INBX] share price is $79.00. The Score for INBX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • INBX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Corcept Therapeutics, Inc. (CORT) is a Sell

Is Corcept Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Corcept Therapeutics, Inc. [CORT] share price is $34.80. The Score for CORT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CORT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

INBX Stock Price Chart

What is Inhibrx Biosciences, Inc.'s stock price today?

  • The Inhibrx Biosciences, Inc. share price today is $79.00
    The current trend is moderately bearish and INBX is experiencing slight buying pressure.

CORT Stock Price Chart

What is Corcept Therapeutics, Inc.'s stock price today?

  • The Corcept Therapeutics, Inc. share price today is $34.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing slight selling pressure.

INBX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.62 Buy
Relative Strength Index (14 RSI): 48.22 Sell
Chaikin Money Flow: 95108 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (79.04 - 87.1) Sell
Bollinger Bands (100): (27.43 - 79.25) Buy

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.88 Sell
Relative Strength Index (14 RSI): 14.83 Sell
Chaikin Money Flow: -8077532 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.63 - 90.59) Sell
Bollinger Bands (100): (69.66 - 84.14) Sell

INBX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 81.07 Sell
20-day SMA: 83.16 Sell
50-day SMA: 77.38 Buy
200-day SMA: 34.4 Buy
8-day EMA: 80.28 Sell
20-day EMA: 81.12 Sell
50-day EMA: 73.58 Buy
200-day EMA: 43.75 Buy

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.24 Sell
20-day SMA: 80.76 Sell
50-day SMA: 77.62 Sell
200-day SMA: 73.92 Sell
8-day EMA: 69.79 Sell
20-day EMA: 76.79 Sell
50-day EMA: 77.19 Sell
200-day EMA: 51.2 Sell

Inhibrx Biosciences, Inc. Earnings Growth & INBX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.25 per share, and an increase next year of $2.01 per share.

Corcept Therapeutics, Inc. Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $3.04 per share.

Inhibrx Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corcept Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):